These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 5481185)
1. [Research on experimental hyperlipemia. IV. Effects of heparin on the inhibitor of the clarifying factor]. Jouzier E; Tixier M; Tayeau F Bord Med; 1970 Sep; 3(9):2017-20. PubMed ID: 5481185 [No Abstract] [Full Text] [Related]
2. [Research on experimental hyperlipemia. 3. Action "in vivo" of the inhibitor of the clarifying factor]. Tayeau F; Jouzier E; Tixier M Bord Med; 1970 Sep; 3(9):2011-4. PubMed ID: 5481184 [No Abstract] [Full Text] [Related]
3. [Research on experimental hyperlipemia. II. Isolation and "in vitro" study of a natural inhibitor of the clarifying factor]. Tayeau F; Jouzier E; Tixier M Bord Med; 1970 Sep; 3(9):1999-2008. PubMed ID: 5481183 [No Abstract] [Full Text] [Related]
4. [Research on experimental hyperlipemia. V. Compared effects of the incubation and of the clarifying factor on the blood serum]. Tayeau F; Jouzier E Bord Med; 1970 Sep; 3(9):2023-8. PubMed ID: 5481186 [No Abstract] [Full Text] [Related]
5. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome]. Nikiforova NV Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418 [No Abstract] [Full Text] [Related]
6. Defective lipemia clearing response to heparin in idiopathic hyperlipemia. KLEIN E; LEVER WF; FEKETE LL J Invest Dermatol; 1959 Sep; 33():91-7. PubMed ID: 14409662 [No Abstract] [Full Text] [Related]
7. Demonstration of lipoprotein lipase activity (free fatty acid release) by in vitro sonic oscillation (sonation) of post-heparin plasma from subjects with "heparin-unresponsive" hyperglyceridemia (hyperlipemia). FURMAN RH; ROBINSON CW Trans Am Clin Climatol Assoc; 1961; 73():30-8. PubMed ID: 13895954 [No Abstract] [Full Text] [Related]
8. A further characterization of lipoprotein lipase. Greten H; Levy RI; Fredrickson DS Biochim Biophys Acta; 1968 Oct; 164(2):185-94. PubMed ID: 5721022 [No Abstract] [Full Text] [Related]
9. Demonstration of lipemia-clearing activity after sublingual administration of heparin potassium in the rabbit. MANGIERI CN; CAIN RA Angiology; 1961 Apr; 12():136-8. PubMed ID: 13766149 [No Abstract] [Full Text] [Related]
12. EFFECTS OF ACIDIC AZOPROTEINS ON PLASMA TRIGLYCERIDE LEVELS AND ON THE HEPARIN-ACTIVATED CLEARING SYSTEM. BROOME JD J Exp Med; 1964 Jan; 119(1):83-104. PubMed ID: 14113117 [TBL] [Abstract][Full Text] [Related]
13. [STUDIES ON THE POST HEPARINIC LIPOPRPTEIN LIPASE ACTIVITY IN 6 CASES OF ESSENTIAL HYPERLIPEMIA]. SANDHOFER F; SAILER S; HERBST M; BRAUNSTEINER H Dtsch Med Wochenschr; 1965 Apr; 90():755-9. PubMed ID: 14282977 [No Abstract] [Full Text] [Related]
19. Effect of heparin and heparin clearing factor on lipoid transport in the rabbits. COMFORT A Biochem J; 1953 Jun; 54(3):xxiii. PubMed ID: 13058945 [No Abstract] [Full Text] [Related]
20. [Research on experimental hyperlipemia. I. Hyperlipemia caused by bloodletting]. Tayeau F; Nivet R; Dumas M; Jouzier E; Tixier M; Grouillé J Bord Med; 1970 Sep; 3(9):1985-96. PubMed ID: 5481182 [No Abstract] [Full Text] [Related] [Next] [New Search]